Molecular Therapy-Oncolytics

Molecular Therapy-Oncolytics,ISSN 2372-7705,eISSN 2372-7705 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

发文量统计区间：2025-09-21 至 2026-09-21，按本站收录文献的发表日期统计。

指标来源：fiveyear

历年影响因子趋势

Molecular Therapy-Oncolytics 最新收录文献

1. JCR分区: N/A CAS分区: N/A 影响因子: N/A

   1. {"_":": What's in a name?","i":["Molecular Therapy Oncology"]}

   PMID:

   38155922

   作者:

   Timothy P Cripe

   期刊:

   Molecular therapy oncolytics PubMed

   DOI:

   10.1016/j.omto.2023.100739

   日期:

   2023-12-19

   查看详情PubMed 原文记录
2. JCR分区: N/A CAS分区: N/A 影响因子: N/A

   2. New advances in cancer therapy targeting TGF-β signaling pathways.

   PMID:

   38144669

   作者:

   Minyue Shou, Hanyu Zhou, Ling Ma

   期刊:

   Molecular therapy oncolytics PubMed

   DOI:

   10.1016/j.omto.2023.100755

   日期:

   2023-12-19

   查看详情PubMed 原文记录
3. JCR分区: N/A CAS分区: N/A 影响因子: N/A

   3. miR-146a: Overcoming coldness in ovarian cancer.

   PMID:

   38144668

   作者:

   Yanqi Ye, Nanhai G Chen

   期刊:

   Molecular therapy oncolytics PubMed

   DOI:

   10.1016/j.omto.2023.100753

   日期:

   2023-12-19

   查看详情PubMed 原文记录
4. JCR分区: N/A CAS分区: N/A 影响因子: N/A

   4. The role and application of vesicles in triple-negative breast cancer: Opportunities and challenges.

   PMID:

   38130701

   作者:

   Ya-Nan Wei, Chun-Yan Yan, Meng-Lu Zhao, Xi-He Zhao

   期刊:

   Molecular therapy oncolytics PubMed

   DOI:

   10.1016/j.omto.2023.100752

   日期:

   2023-12-19

   Extracellular vesicles (EVs) carry DNA, RNA, protein, and other substances involved in intercellular crosstalk and can be used for the targeted delivery of drugs. Triple-negative breast cancer (TNBC) is rich in recurrent and metastatic disease and lacks therapeutic targets. Studies have proved the r…

   查看详情PubMed 原文记录
5. JCR分区: N/A CAS分区: N/A 影响因子: N/A

   5. Pre-treatment with systemic agents for advanced NSCLC elicits changes in the phenotype of autologous T cell therapy products.

   PMID:

   38075248

   作者:

   Charlotte O'Brien Gore, Amy Billman, Suchete Hunjan, Jayne Colebrook, Desmond Choy, Wilson Li, Jack Haynes, Jennifer Wade, Emily Hobern, Louisa McDonald, Sophie Papa, Martijn Brugman, Shahram Kordasti, Claudia Montiel-Equihua

   期刊:

   Molecular therapy oncolytics PubMed

   DOI:

   10.1016/j.omto.2023.100749

   日期:

   2023-12-19

   The antitumor activity of adoptive T cell therapies (ACT) is highly dependent on the expansion, persistence, and continued activity of adoptively transferred cells. Clinical studies using ACTs have revealed that products that possess and maintain less differentiated phenotypes, including memory and …

   查看详情PubMed 原文记录
6. JCR分区: N/A CAS分区: N/A 影响因子: N/A

   6. Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancer.

   PMID:

   38075247

   作者:

   Jessica A Minott, Jacob P van Vloten, Jake G E Yates, Lisa A Santry, Kathy Matuszewska, Madison Pereira, Melanie M Goens, Alicia M Viloria-Petit, Geoffrey A Wood, Khalil Karimi, James J Petrik, Byram W Bridle, Sarah K Wootton

   期刊:

   Molecular therapy oncolytics PubMed

   DOI:

   10.1016/j.omto.2023.100748

   日期:

   2023-12-19

   Immunotherapies revive host immune responses against tumors by stimulating innate and adaptive immune effector cells with antitumor functions. Thus, detailed studies of immunological cell phenotypes and functions within the tumor microenvironment (TME) following immunotherapy treatments is critical …

   查看详情PubMed 原文记录
7. JCR分区: N/A CAS分区: N/A 影响因子: N/A

   7. {"_":"Beyond , emerging roles and targeting strategies of other enolases in cancers.","i":["ENO1"]}

   PMID:

   38075246

   作者:

   Jiaojiao Ni, Yihui Huang, Chaoqun Li, Qian Yin, Jieer Ying

   期刊:

   Molecular therapy oncolytics PubMed

   DOI:

   10.1016/j.omto.2023.100750

   日期:

   2023-12-19

   Aerobic glycolysis is a hallmark property of cancer metabolism. Enolase is a glycolytic enzyme that catalyzes the conversion of 2-phosphoglycerate into phosphoenolpyruvate. In mammals, enolases exist in three isoforms, encoded by the genes , , and . The altered expression of enolases is a common occ…

   查看详情PubMed 原文记录
8. JCR分区: N/A CAS分区: N/A 影响因子: N/A

   8. Targeting mesothelin in cancer.

   PMID:

   38075245

   作者:

   Cem Elbi

   期刊:

   Molecular therapy oncolytics PubMed

   DOI:

   10.1016/j.omto.2023.100756

   日期:

   2023-12-19

   查看详情PubMed 原文记录
9. JCR分区: N/A CAS分区: N/A 影响因子: N/A

   9. {"_":"Treatment with the PPARα agonist fenofibrate improves the efficacy of CD8 T cell therapy for melanoma.","sup":["+"]}

   PMID:

   38075243

   作者:

   Mohadeseh Hasanpourghadi, Arezki Chekaoui, Sophia Kurian, Raj Kurupati, Robert Ambrose, Wynetta Giles-Davis, Amara Saha, Xu Xiaowei, Hildegund C J Ertl

   期刊:

   Molecular therapy oncolytics PubMed

   DOI:

   10.1016/j.omto.2023.100744

   日期:

   2023-12-19

   Adoptive transfer of tumor antigen-specific CD8 T cells can limit tumor progression but is hampered by the T cells' rapid functional impairment within the tumor microenvironment (TME). This is in part caused by metabolic stress due to lack of oxygen and glucose. Here, we report that fenofibrate trea…

   查看详情PubMed 原文记录
10. JCR分区: N/A CAS分区: N/A 影响因子: N/A

    10. Gaining insights into virotherapy with canine models.

    PMID:

    38075242

    作者:

    Jacob L Léger, Lee-Hwa Tai

    期刊:

    Molecular therapy oncolytics PubMed

    DOI:

    10.1016/j.omto.2023.100754

    日期:

    2023-12-19

    查看详情PubMed 原文记录